Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

News Conference News TVT 2023

‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients

Michael O'Riordan

June 09, 2023

News Conference News TVT 2023

Latest-Generation MitraClip Devices Make Strides Against Residual MR

Shelley Wood

June 09, 2023

News Conference News TVT 2023

Surgical Outcomes After Failed TEER: More Insights, Red Flags From CUTTING-EDGE

Shelley Wood

June 08, 2023

Presentation TVT 2022

Post-TAVR Heart Failure: Mechanism, Incidence, Risk Factors, and Treatment

Presenter: Chetan Huded

June 10, 2022

News Conference News TVT 2021

Post-TAVI Pacemaker Rates Down in the US, but ‘Still Quite High’

Todd Neale

July 23, 2021

News Conference News TVT 2021

TAVI Outcomes Similar in Low-Risk Bicuspid, Tricuspid Aortic Stenosis at 1 Year

Todd Neale

July 20, 2021

News Conference News TVT 2020

Antithrombotics After PFO Closure: Much to Discuss, Little Data to Inform

Yael L. Maxwell

June 26, 2020

News Conference News TVT 2020

Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events

Michael O'Riordan

June 23, 2020

News Conference News TVT 2020

Skipping Predilatation in Low-risk TAVR Patients Does Not Mar Outcomes

L.A. McKeown

June 19, 2020

News Conference News TVT 2019

Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR

Michael O'Riordan

June 19, 2019

News Conference News TVT 2019

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

Shelley Wood

June 13, 2019

Presentation TVT 2019

Incidence, Trends, Risk Factors, and Comparison With Surgery for Early Stroke After TAVR: Reports From PARTNER and the TVT Registry (in High- and Intermediate-Risk Patients)

Presenter: Samir Kapadia

June 13, 2019

News Conference News TVT 2017

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Shelley Wood

June 16, 2017

News Conference News TVT 2016

When Is Sick Too Sick for TAVR? Physicians Grapple With Identifying Futile Care

Michael O'Riordan

June 20, 2016

News Conference News TVT 2016

Valve Degeneration Data Dearth Spurs Calls for Universal Definitions and Clinical Guidance

Shelley Wood

June 20, 2016

News Conference News TVT 2016

What TAVR Needs Next . . . and What It’s Getting

Shelley Wood

June 17, 2016

News Conference News TVT 2016

To Intervene or Not to Intervene When the TAVR Patient Has CAD: New Insights

Shelley Wood

June 17, 2016

Presentation TVT 2016

Imaging Preferences and Hemodynamic Assessments to Determine the Severity of PVR During TAVR: Factors Influencing Treatment Thresholds

Presenter: Didier Tchetche

June 16, 2016

Presentation TVT 2013

A Mulitcenter Evaluation of Annulus Rupture After TAVR: Preprocedural CT Risk Factors

Presenter: Marco Barbanti

June 13, 2013

Advertisement

‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients

Latest-Generation MitraClip Devices Make Strides Against Residual MR

Surgical Outcomes After Failed TEER: More Insights, Red Flags From CUTTING-EDGE

Post-TAVR Heart Failure: Mechanism, Incidence, Risk Factors, and Treatment

Post-TAVI Pacemaker Rates Down in the US, but ‘Still Quite High’

TAVI Outcomes Similar in Low-Risk Bicuspid, Tricuspid Aortic Stenosis at 1 Year

Antithrombotics After PFO Closure: Much to Discuss, Little Data to Inform

Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events

Skipping Predilatation in Low-risk TAVR Patients Does Not Mar Outcomes

Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR

Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate

Incidence, Trends, Risk Factors, and Comparison With Surgery for Early Stroke After TAVR: Reports From PARTNER and the TVT Registry (in High- and Intermediate-Risk Patients)

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

When Is Sick Too Sick for TAVR? Physicians Grapple With Identifying Futile Care

Valve Degeneration Data Dearth Spurs Calls for Universal Definitions and Clinical Guidance

What TAVR Needs Next . . . and What It’s Getting

To Intervene or Not to Intervene When the TAVR Patient Has CAD: New Insights

Imaging Preferences and Hemodynamic Assessments to Determine the Severity of PVR During TAVR: Factors Influencing Treatment Thresholds

A Mulitcenter Evaluation of Annulus Rupture After TAVR: Preprocedural CT Risk Factors

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content